Silence Therapeutics (SLN) Goodwill (2019 - 2025)
Silence Therapeutics (SLN) has disclosed Goodwill for 7 consecutive years, with $10.6 million as the latest value for Q4 2025.
- Quarterly Goodwill rose 13.09% to $10.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Dec 2025, up 13.09% year-over-year, with the annual reading at $10.6 million for FY2025, 13.09% up from the prior year.
- Goodwill hit $10.6 million in Q4 2025 for Silence Therapeutics, roughly flat from $10.6 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $10.6 million in Q4 2025 to a low of $9.4 million in Q3 2024.
- Historically, Goodwill has averaged $10.0 million across 5 years, with a median of $9.8 million in 2024.
- Biggest five-year swings in Goodwill: decreased 8.21% in 2022 and later rose 13.09% in 2025.
- Year by year, Goodwill stood at $10.2 million in 2021, then fell by 8.21% to $9.4 million in 2022, then grew by 3.58% to $9.7 million in 2023, then fell by 3.48% to $9.4 million in 2024, then increased by 13.09% to $10.6 million in 2025.
- Business Quant data shows Goodwill for SLN at $10.6 million in Q4 2025, $10.6 million in Q3 2025, and $10.6 million in Q2 2025.